AROVAST F 10/160 TABLET

Product Description

AROVAST F 10/160 TABLET
Powerful Dual-Lipid Therapy with Atorvastatin 10mg + Fenofibrate 160mg

Product Description:
AROVAST F 10/160 TABLET is a high-strength lipid-lowering combination of Atorvastatin (10mg) and Fenofibrate (160mg), developed for the effective management of mixed dyslipidemia, elevated triglycerides, and cholesterol imbalances. This synergistic formulation helps lower LDL and triglycerides while improving HDL levelsmaking it ideal for patients at risk of cardiovascular events, particularly those with diabetes or metabolic syndrome.

Manufactured by Agrosaf Pharmaceuticals Pvt. Ltd. under WHO-GMP-certified standards, AROVAST F 10/160 ensures premium quality, safety, and consistent therapeutic outcomes.

Key Benefits:

• Dual-action lipid regulation in a single daily dose

• Effectively lowers LDL, VLDL, and triglycerides

• Increases HDL (good cholesterol) for enhanced heart protection

• Ideal for diabetic dyslipidemia and high cardiovascular risk patients

• Improves lipid profile for long-term cardiac care

Therapeutic Indications:

• Mixed dyslipidemia and hypertriglyceridemia

• Diabetic lipid disorders

• Cardiovascular risk reduction in metabolic syndrome

• Adjunct therapy when statin or fibrate monotherapy is insufficient

Target Buyers:
Designed for cardiology distributors, hospital pharmacies, diabetic care suppliers, and B2B buyers seeking advanced combination lipid-lowering therapies.

Packaging:

Securely packed in blister strips with bulk packaging options available for hospitals, clinics, and wholesale buyers.

AROVAST F 10/160 TABLET Complete lipid control. Trusted by professionals. Manufactured by Agrosaf Pharmaceuticals your reliable B2B partner in cardiovascular and metabolic health.